WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007098264) USE OF RASAGILINE FOR THE TREATMENT OF MULTIPLE SYSTEM ATROPHY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/098264    International Application No.:    PCT/US2007/004884
Publication Date: 30.08.2007 International Filing Date: 21.02.2007
IPC:
A61F 13/02 (2006.01)
Applicants: TEVA PHARMACEUTICAL INDUSTRIES, LTD. [IL/IL]; 5 Basel Street, P.O. Box 3190, 49131 Petach-Tikva (IL) (AE, AG, AL, AM, AT, AU, AZ, BA, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SV, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW only).
TEVA PHARMACEUTICALS USA, INC. [US/US]; 1090 Horsham Road, North Wales, PA 19454 (US) (BB only).
POEWE, Werner [--/AT]; (AT) (For US Only)
Inventors: POEWE, Werner; (AT)
Agent: WHITE, John, P.; Cooper & Dunham LLP, 1185 Avenue of the Americas, New York, NY 10036 (US)
Priority Data:
60/775,147 21.02.2006 US
60/874,341 12.12.2006 US
Title (EN) USE OF RASAGILINE FOR THE TREATMENT OF MULTIPLE SYSTEM ATROPHY
(FR) UTILISATION DE RASAGILINE POUR TRAITER UNE ATROPHIE MULTISYSTÉMATISÉE
Abstract: front page image
(EN)Disclosed is a method for the treatment of Multiple System Atrophy comprising administering to a subject an amount of R(+) -N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof.
(FR)L'invention concerne une méthode pour traiter une atrophie qui comprend l'administration à un sujet d'une quantité de R(+)-N-propargyl-1-aminoindane ou d'un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)